$DORM
Dorman Products, Inc. Stock $dorm

$dorm Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000086878024000020 Filed on May 07, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q2
Revenue	$503.0M	$468.7M	$466.7M
YoY Change	7.76%		11.82%
Cost Of Revenue	$303.6M	$287.3M	$322.3M
YoY Change	-5.81%		16.81%
Gross Profit	$199.4M	$181.4M	$144.5M
YoY Change	38.02%		2.09%
Gross Profit Margin	39.65%	38.71%	30.95%
Selling, General & Admin	$126.9M	$127.0M	$126.4M
YoY Change	0.46%		37.26%
% of Gross Profit	63.67%	70.0%	87.46%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$14.35M	$13.85M	$13.54M
YoY Change	6.0%		37.36%
% of Gross Profit	7.2%	7.63%	9.37%
Operating Expenses	$126.9M	$127.0M	$126.4M
YoY Change	0.46%		37.26%
Operating Profit	$72.45M	$54.44M	$18.11M
YoY Change	299.98%		-63.38%
Interest Expense	-$10.20M	$10.61M	$11.95M
YoY Change	-185.35%		663.77%
% of Operating Profit	-14.08%	19.48%	65.99%
Other Income/Expense, Net	$136.0K	-$40.00K	$357.0K
YoY Change	-61.9%		221.62%
Pretax Income	$62.39M	$43.79M	$6.518M
YoY Change	857.13%		-86.42%
Income Tax	$14.98M	$10.97M	$835.0K
% Of Pretax Income	24.01%	25.04%	12.81%
Net Earnings	$47.41M	$32.83M	$5.683M
YoY Change	734.24%		-85.01%
Net Earnings / Revenue	9.43%	7.0%	1.22%
Basic Earnings Per Share	$1.53	$1.05	$0.18
Diluted Earnings Per Share	$1.53	$1.05	$0.18
COMMON SHARES
Basic Shares Outstanding	31.01M shares	31.09M shares	31.44M shares
Diluted Shares Outstanding	31.07M shares	31.25M shares	31.54M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$47.47M	$34.43M	$33.31M
YoY Change	42.51%		-35.91%
Cash & Equivalents	$47.47M	$34.43M	$33.31M
Short-Term Investments
Other Short-Term Assets	$39.01M	$22.06M	$40.17M
YoY Change	-2.89%		48.98%
Inventory	$620.4M	$620.0M	$686.9M
Prepaid Expenses
Receivables	$526.2M	$486.4M	$429.3M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.233B	$1.163B	$1.190B
YoY Change	3.64%		5.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$165.8M	$162.4M	$151.5M
YoY Change	9.39%		28.5%
Goodwill	$443.0M	$443.3M	$443.3M
YoY Change	-0.07%		124.86%
Intangibles	$290.3M	$295.9M	$317.0M
YoY Change	-8.43%		83.6%
Long-Term Investments
YoY Change
Other Assets	$51.16M	$49.99M	$50.50M
YoY Change	1.31%		10.32%
Total Long-Term Assets	$1.053B	$1.057B	$1.071B
YoY Change	-1.7%		69.96%
TOTAL ASSETS
Total Short-Term Assets	$1.233B	$1.163B	$1.190B
Total Long-Term Assets	$1.053B	$1.057B	$1.071B
Total Assets	$2.286B	$2.220B	$2.261B
YoY Change	1.11%		28.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$164.7M	$131.5M	$145.7M
YoY Change	13.02%		-28.39%
Accrued Expenses	$264.4M	$240.5M	$233.3M
YoY Change	13.33%		2.53%
Deferred Revenue
YoY Change
Short-Term Debt	$69.46M	$81.16M	$215.5M
YoY Change	-67.76%		-6.06%
Long-Term Debt Due	$15.63M	$12.50M	$12.50M
YoY Change	25.0%
Total Short-Term Liabilities	$514.1M	$465.6M	$606.9M
YoY Change	-15.29%		-8.09%
LONG-TERM LIABILITIES
Long-Term Debt	$461.2M	$467.3M	$479.4M
YoY Change	-3.81%
Other Long-Term Liabilities	$10.17M	$10.23M	$16.75M
YoY Change	-39.31%		227.32%
Total Long-Term Liabilities	$471.4M	$477.6M	$496.2M
YoY Change	-5.01%		9596.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$514.1M	$465.6M	$606.9M
Total Long-Term Liabilities	$471.4M	$477.6M	$496.2M
Total Liabilities	$985.5M	$943.2M	$1.103B
YoY Change	-10.66%		65.77%
SHAREHOLDERS EQUITY
Retained Earnings	$1.099B	$1.076B	$961.6M
YoY Change	14.24%		5.65%
Common Stock	$107.0M	$102.5M	$90.73M
YoY Change	17.96%		9.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.201B	$1.174B	$1.049B
YoY Change
Total Liabilities & Shareholders Equity	$2.286B	$2.220B	$2.261B
YoY Change	1.11%		28.36%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q2
OPERATING ACTIVITIES
Net Income	$47.41M	$32.83M	$5.683M
YoY Change	734.24%		-85.01%
Depreciation, Depletion And Amortization	$14.35M	$13.85M	$13.54M
YoY Change	6.0%		37.36%
Cash From Operating Activities	$63.35M	$51.98M	$26.21M
YoY Change	141.7%		84.94%
INVESTING ACTIVITIES
Capital Expenditures	$11.94M	$10.76M	$10.54M
YoY Change	13.27%		-219.02%
Acquisitions		$0.00	-$267.0K
YoY Change
Other Investing Activities	$0.00	$0.00	$267.0K
YoY Change	-100.0%
Cash From Investing Activities	-$11.94M	-$10.76M	-$10.27M
YoY Change	16.21%		16.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$3.125M	$3.125M
YoY Change
Cash From Financing Activities	-38.36M	-$43.57M	-$28.66M
YoY Change	33.83%		326.28%
NET CHANGE
Cash From Operating Activities	63.35M	$51.98M	$26.21M
Cash From Investing Activities	-11.94M	-$10.76M	-$10.27M
Cash From Financing Activities	-38.36M	-$43.57M	-$28.66M
Net Change In Cash	13.05M	-$2.381M	-$12.73M
YoY Change	-202.56%		805.84%
FREE CASH FLOW
Cash From Operating Activities	$63.35M	$51.98M	$26.21M
Capital Expenditures	$11.94M	$10.76M	$10.54M
Free Cash Flow	$51.41M	$41.23M	$15.67M
YoY Change	228.04%		-31.93%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-2217000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	5683000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1049144000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	287255000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	322261000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	181446000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	144477000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	127008000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	126363000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	54438000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	18114000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	10605000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	11953000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-40000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	357000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	43793000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6518000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10965000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	835000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	32828000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	5683000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1099000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	119000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	31729000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5802000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31140000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31436000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31250000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31537000	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34433000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36814000	usd
CY2024Q1	dorm	Allowance For Doubtful Accounts And Customer Credits AllowanceForDoubtfulAccountsAndCustomerCredits	3513000	usd
CY2023Q4	dorm	Allowance For Doubtful Accounts And Customer Credits AllowanceForDoubtfulAccountsAndCustomerCredits	3518000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	486352000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	526867000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	619972000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	637375000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22062000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	32653000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	1162819000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1233709000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	162439000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	160113000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	105714000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	103476000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	443296000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	443889000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	295880000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	301556000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	49989000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	49664000	usd
CY2024Q1	us-gaap	Assets Assets	2220137000	usd
CY2023Q4	us-gaap	Assets Assets	2292407000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	131478000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	176664000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	18206000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	119000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	32828000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	5683000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	23971000	usd
CY2024Q1	dorm	Accrued Customer Rebates And Returns AccruedCustomerRebatesAndReturns	186332000	usd
CY2023Q4	dorm	Accrued Customer Rebates And Returns AccruedCustomerRebatesAndReturns	204495000	usd
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	81160000	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	92760000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	12500000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	15625000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	35944000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	33636000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	465620000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	547151000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	467338000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	467239000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	93105000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	91262000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10233000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9627000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	9346000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8925000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31011870	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31011870	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31299770	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31299770	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	310000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	313000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	102211000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	101045000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1075663000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1069435000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3689000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2590000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1174495000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1168203000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2220137000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2292407000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1168203000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	340000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2931000	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	27136000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-1572000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1099000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	32828000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1174495000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1042631000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1049000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2312000	usd
CY2023Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	433000	usd
CY2024Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	13851000	usd
CY2023Q2	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	13540000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	11000	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2744000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	475000	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2931000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	2334000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-40454000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4673000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-17235000	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-68935000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2377000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	591000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	918000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2130000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-45084000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-34258000	usd
CY2024Q1	dorm	Increase Decrease In Accrued Customer Rebates And Returns IncreaseDecreaseInAccruedCustomerRebatesAndReturns	-18156000	usd
CY2023Q2	dorm	Increase Decrease In Accrued Customer Rebates And Returns IncreaseDecreaseInAccruedCustomerRebatesAndReturns	-21683000	usd
CY2024Q1	dorm	Increase Decrease In Accrued Compensation And Other Liabilities IncreaseDecreaseInAccruedCompensationAndOtherLiabilities	5976000	usd
CY2023Q2	dorm	Increase Decrease In Accrued Compensation And Other Liabilities IncreaseDecreaseInAccruedCompensationAndOtherLiabilities	-3691000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	51980000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	26210000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-267000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10755000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10537000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10755000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10270000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	11600000	usd
CY2023Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	23900000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3125000	usd
CY2023Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3125000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	340000	usd
CY2023Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1049000	usd
CY2024Q1	dorm	Purchase And Cancellation Of Common Stock PurchaseAndCancellationOfCommonStock	27609000	usd
CY2023Q2	dorm	Purchase And Cancellation Of Common Stock PurchaseAndCancellationOfCommonStock	433000	usd
CY2024Q1	dorm	Proceeds Payments From Other Stock Related Activity ProceedsPaymentsFromOtherStockRelatedActivity	-1573000	usd
CY2023Q2	dorm	Proceeds Payments From Other Stock Related Activity ProceedsPaymentsFromOtherStockRelatedActivity	-2254000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-43567000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-28663000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-39000	usd
CY2023Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-4000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2381000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12727000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	36814000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	46034000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	34433000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	33307000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	10397000	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	11534000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	839000	usd
CY2023Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1055000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Finance Receivables ProceedsFromSaleOfFinanceReceivables	285218000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Finance Receivables ProceedsFromSaleOfFinanceReceivables	237739000	usd
CY2024Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	26431000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	29750000	usd
CY2024Q1	us-gaap	Inventory Raw Materials And Purchased Parts Net Of Reserves InventoryRawMaterialsAndPurchasedPartsNetOfReserves	172200000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Purchased Parts Net Of Reserves InventoryRawMaterialsAndPurchasedPartsNetOfReserves	211805000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	412547000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	387668000	usd
CY2024Q1	us-gaap	Inventory Supplies Net Of Reserves InventorySuppliesNetOfReserves	8794000	usd
CY2023Q4	us-gaap	Inventory Supplies Net Of Reserves InventorySuppliesNetOfReserves	8152000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	619972000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	637375000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	443889000	usd
CY2024Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-593000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	443296000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	355317000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	59437000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	295880000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	355317000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	53761000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	301556000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5600000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5500000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	43793000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6518000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	52000000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	468701000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	466738000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	257554	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	97.33
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	171940	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	99.45
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	44435	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	89.84
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	16085	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	128.96
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	368974	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	97.83
CY2024Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	400000	usd
CY2023Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	400000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	311217	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	86.52
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6046	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	62.75
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	305171	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	86.99
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M12D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3193000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	195683	shares
CY2024Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	82.99
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y7M6D
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2844000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	319000	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	237000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	32828000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	5683000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31140000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31436000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	110000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	101000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31250000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31537000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.250
CY2023Q2	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.128
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4600000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	4300000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000868780-24-000020-index-headers.html	Edgar Link	pending
0000868780-24-000020-index.html	Edgar Link	pending
0000868780-24-000020.txt	Edgar Link	pending
0000868780-24-000020-xbrl.zip	Edgar Link	pending
dorm-20240330.htm	Edgar Link	pending
dorm-20240330.xsd	Edgar Link	pending
dorm-20240330x10qexx311.htm	Edgar Link	pending
dorm-20240330x10qexx312.htm	Edgar Link	pending
dorm-20240330x10qexx32.htm	Edgar Link	pending
dorm-20240330_g1.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
dorm-20240330_cal.xml	Edgar Link	unprocessable
dorm-20240330_lab.xml	Edgar Link	unprocessable
dorm-20240330_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
dorm-20240330_htm.xml	Edgar Link	completed
dorm-20240330_def.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DORM
Dorman Products, Inc. Stock $dorm

2024 Q2 Form 10-Q Financial Statement

#000086878024000020 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DORM Dorman Products, Inc. Stock $dorm

2024 Q2 Form 10-Q Financial Statement

#000086878024000020 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DORM
Dorman Products, Inc. Stock $dorm